BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Megalabs USA Announces Launch of Two New Products in North American Market: Abintra and Glutapak R

  Megalabs USA, a subsidiary of Megalabs Inc., that manufactures, markets and distributes pharmaceutical products and nutritional supplements throughout the Americas, has added two new products, Abintra and Glutapak R, to its North American portfolio.

  August 24, 2022

   · 

  3 min read
• Genetown

  Privo Technologies, Inc. Announces Publication in Nature Communications

  Privo Technologies, Inc. announced that Nature Communications published the results of the evaluation of efficacy and safety data collected using PRV111 on animal models of oral cancer and clinical trial in patients with oral cavity squamous cell carcinoma.

  August 24, 2022

   · 

  3 min read
• Business

  MediGO Launches New Software to Help Streamline Response to Organ Donor Referrals

  MediGO , a Baltimore-based health care supply chain technology company, is helping transform the start of the organ donation and transplantation process with the launch of its new software solution known as Organ TeamLink.

  August 24, 2022

   · 

  2 min read
• Business

  CANbridge Announces Financial Results and Corporate Updates for Six Months Ended June 30, 2022

  CANbridge Pharmaceuticals, Inc. today announced financial results for the six months ended 2022 and a corporate update.

  August 24, 2022

   · 

  12 min read
• Asieris Pharmaceuticals (688176.SH) Issued 2022 Semi-Annual Report: Accelerated Global Clinical Development and Progressive Implementation of Its Integrated Diagnosis-Treatment Commercialization Strategy

  Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, issued its 2022 semi-annual report today.

  August 24, 2022

   · 

  7 min read
• Oxurion To Present at Upcoming Scientific and Investor Conferences

  Oxurion NV announced that it will participate in three upcoming conferences.

  August 24, 2022

   · 

  1 min read
• BioMidwest

  Tampa General Hospital Is a Top-10 Employer in the State of Florida as Recognized by Forbes Magazine

  Tampa General Hospital’s commitment to supporting its team members by encouraging personal and professional development has been recognized by Forbes Magazine, naming Tampa General a top-10 employer in the state of Florida.

  August 24, 2022

   · 

  10 min read
• AB Science announces that it has filed an application for conditional Marketing Authorization to EMA for masitinib in the treatment of ALS

  PRESS RELEASE AB SCIENCE ANNOUNCES FILING OF MARKETING AUTHORIZATION APPLICATION FOR ALSITEK IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS ( ALS ) AND ITS VALIDATION BY THE EUROPEAN MEDICINES AGENCY (EMA).

  August 24, 2022

   · 

  9 min read
• BioMidwest

  Blue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom

  Blue Water Vaccines Inc. today announced that scientists from its research partner, The University of Oxford, will present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom on Monday, September 5th , 2022.

  August 24, 2022

   · 

  4 min read
• Pharm Country

  ORBEYE Exoscope Blue Light Imaging Mode Now Available for Use in Neurosurgery

  Olympus announced the availability of the Blue Light Imaging Mode with the ORBEYE™ 4K 3D exoscope system.

  August 24, 2022

   · 

  4 min read